paralyzed patient

American billionaire Elon Musk's neurotechnology company Neuralink announced yesterday (November 20) that it has received approval to conduct its first clinical trial in Canada.

Scientists have initially succeeded in using wireless technology to control the brains of the paralyzed patients, enabling them to walk back to normal.

Dr Oxley is also proud to say that the device will limit the risk of infection of electronic chip surgery surgeries in the brain because the brain is completely free of cutlery.